Transplantation is the only curative treatment option available for patients suffering from end‐
stage organ failure, improving their quality of life and long‐term survival. However, because …

Lung endothelia in the arteries, capillaries, and veins are heterogeneous in structure and
function. Lung capillaries in particular represent a unique vascular niche, with a thin yet …

Decellularization of tissues and organs has recently become a promising approach in tissue
engineering and regenerative medicine to circumvent the challenges of organ donation and …

Lung transplantation is currently the only curative treatment for patients with end-stage lung
disease; however, donor organ shortage and the need for intense immunosuppression limit …

Biomaterials have been used for a long time in the field of medicine. Since the success of
“tissue engineering” pioneered by Langer and Vacanti in 1993, tissue engineering studies …

Clinical lung transplantation has rapidly established itself as the gold standard of treatment
for end‐stage lung diseases in a restricted group of patients since the first successful lung …

Bioengineering the lung using recellularized scaffolds could offer a curative option for
patients with end-stage organ failure but its accomplishment remains unclear in the short …

Chronic lung diseases are one of the leading causes of death worldwide. Lung
transplantation is currently the only causal therapeutic for lung diseases, which is restricted …

Despite the discovery more than 15 years ago that patients with hereditary pulmonary
arterial hypertension (HPAH) inherit BMP type 2 receptor (BMPR2) mutations, it is still …

Three-dimensional (3D) bioprinting, or additive manufacturing, is a rapid fabrication
technique with the foremost objective of creating biomimetic tissue and organ replacements …